- Home
- CNO vs VKTX Comparison
CNO vs VKTX Comparison
Compare CNO & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNO
- VKTX
- Stock Information
- Founded
- CNO 1979
- VKTX 2012
- Country
- CNO United States
- VKTX United States
- Employees
- CNO N/A
- VKTX N/A
- Industry
- CNO Accident &Health Insurance
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CNO Finance
- VKTX Health Care
- Exchange
- CNO Nasdaq
- VKTX Nasdaq
- Market Cap
- CNO 3.6B
- VKTX 3.5B
- IPO Year
- CNO 1987
- VKTX 2015
- Fundamental
- Price
- CNO $37.62
- VKTX $40.03
- Analyst Decision
- CNO Hold
- VKTX Strong Buy
- Analyst Count
- CNO 5
- VKTX 13
- Target Price
- CNO $43.40
- VKTX $86.92
- AVG Volume (30 Days)
- CNO 764.0K
- VKTX 4.6M
- Earning Date
- CNO 07-28-2025
- VKTX 07-23-2025
- Dividend Yield
- CNO 1.81%
- VKTX N/A
- EPS Growth
- CNO N/A
- VKTX N/A
- EPS
- CNO 2.77
- VKTX N/A
- Revenue
- CNO $4,382,400,000.00
- VKTX N/A
- Revenue This Year
- CNO N/A
- VKTX N/A
- Revenue Next Year
- CNO $3.19
- VKTX $338.60
- P/E Ratio
- CNO $13.56
- VKTX N/A
- Revenue Growth
- CNO 0.96
- VKTX N/A
- 52 Week Low
- CNO $31.40
- VKTX $18.92
- 52 Week High
- CNO $43.20
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- CNO 53.08
- VKTX 69.97
- Support Level
- CNO $35.81
- VKTX $39.35
- Resistance Level
- CNO $38.32
- VKTX $41.68
- Average True Range (ATR)
- CNO 0.80
- VKTX 2.06
- MACD
- CNO 0.20
- VKTX 0.56
- Stochastic Oscillator
- CNO 77.27
- VKTX 84.10
About CNO CNO Financial Group Inc.
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.